2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Jens Mogensen et al.|European Heart Journal|2023Cited by 2.3k
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Juan Pablo Kaski, Tao Ding et al.|JAMA Cardiology|2019Cited by 248
Treatments targeting inotropyChristoph Maack, Alexandre Mebazaa, Thomas Eschenhagen et al.|European Heart Journal|2018Cited by 227
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?Giovanni Duro, Paolo Colomba, Carmela Zizzo et al.|International Journal of Molecular Sciences|2018Cited by 99
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the <scp>AC‐TIVE</scp> study, an <scp>Italian nationwide survey</scp>Marco Merlo, Gianfranco Sinagra, Linda Pagura et al.|European Journal of Heart Failure|2022Cited by 91